Literature DB >> 12615952

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.

Richard L Hauger1, Dimitri E Grigoriadis, Mary F Dallman, Paul M Plotsky, Wylie W Vale, Frank M Dautzenberg.   

Abstract

Receptors for corticotropin-releasing factor (CRF) are members of a family of G protein-coupled receptors ("Family B") that respond to a variety of structurally dissimilar releasing factors, neuropeptides, and hormones (including secretin, growth hormone-releasing factor, calcitonin, parathyroid hormone, pituitary adenylate cyclase-activating polypeptide, and vasoactive intestinal polypeptide) and signal through the cyclic AMP and/or calcium pathways. To date, three genes encoding additional CRF-like peptides (urocortins) have been identified in mammals. The urocortins and CRF bind with differential ligand selectivity at the two mammalian CRF receptors. This report was prepared by the International Union of Pharmacology Subcommittee on CRF Receptors, to summarize the current state of CRF receptor biology and to propose changes in the classification and nomenclature of CRF ligands and receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615952     DOI: 10.1124/pr.55.1.3

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  113 in total

1.  Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.

Authors:  Guillaume Gourcerol; S Vincent Wu; Pu-Qing Yuan; Hung Pham; Marcel Miampamba; Muriel Larauche; Paul Sanders; Tomofumi Amano; Agata Mulak; Eunok Im; Charalabos Pothoulakis; Jean Rivier; Yvette Taché; Mulugeta Million
Journal:  Gastroenterology       Date:  2011-01-26       Impact factor: 22.682

2.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

3.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

4.  The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Authors:  Katharina Schulz; Claudia Rutz; Carolin Westendorf; Ingrid Ridelis; Susanne Vogelbein; Jens Furkert; Antje Schmidt; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

5.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 6.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

Review 7.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

Review 8.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

9.  Maternal profiling of corticotropin-releasing factor receptor 2 deficient mice in association with restraint stress.

Authors:  Kimberly L D'Anna; Sharon A Stevenson; Stephen C Gammie
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

Review 10.  Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Authors:  Richard L Hauger; Victoria Risbrough; Robert H Oakley; J Alberto Olivares-Reyes; Frank M Dautzenberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.